Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54.4M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
55.7M
-
Shares change
-
-2.37M
-
Total reported value, excl. options
-
$100M
-
Value change
-
-$19.4M
-
Number of buys
-
44
-
Number of sells
-
-30
-
Price
-
$1.80
Significant Holders of CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM) as of Q4 2024
96 filings reported holding CLYM - CLIMB BIO, INC. - Common Stock, par value $0.0001 per share as of Q4 2024.
CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.7M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (31.4M shares), JANUS HENDERSON GROUP PLC (3.18M shares), Samsara BioCapital, LLC (2.61M shares), Boxer Capital Management, LLC (2.6M shares), BlackRock, Inc. (2.31M shares), VANGUARD GROUP INC (1.51M shares), Deep Track Capital, LP (1.04M shares), BANK OF AMERICA CORP /DE/ (1.03M shares), Ally Bridge Group (NY) LLC (760K shares), and GEODE CAPITAL MANAGEMENT, LLC (661K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.